Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
Detailed price information for Black Diamond Therapeutics Inc (BDTX-Q) from The Globe and Mail including charting and trades.
Research Analysts Set Expectations for BDTX FY2024 Earnings
Equities research analysts at HC Wainwright upped their FY2024 earnings per share (EPS) estimates for shares of Black Diamond ...
Pharmaceutical Technology3d
Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment
Mustang Bio has received orphan drug designation from the US Food and Drug Administration (FDA) for MB-108, a herpes simplex ...
Black Diamond Therapeutics Reports Promising Q3 2024 Results
Black Diamond Therapeutics, Inc. ( (BDTX) ) has released its Q3 earnings. Here is a breakdown of the information Black Diamond Therapeutics, ...
Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Announced encouraging initial Phase 2 data of BDTX-1535 in patients with recurrent EGFRm NSCLC with a broad spectrum of classical, non-classical, ...